Evidence map›Paper›PMID 42457551›Full record

ArticleThe Journal of veterinary medical science2026

Gut microbiome changes in a captive giant panda with cardiovascular disease.

Xueying Wang, Ryoji Umemoto, Mizuki Kato, Takashi Hayakawa

Abstract readCase Reports
In one paragraph

Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xueying WangGraduate School of Environment Science, Hokkaido University, Hokkaido, Japan.
Ryoji UmemotoKobe Oji Zoo, Hyogo, Japan.
Mizuki KatoKobe Oji Zoo, Hyogo, Japan.
Takashi HayakawaFaculty of Environment Earth Science, Hokkaido University, Hokkaido, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between gut bacteria and their host is vital for the early diagnosis and treatment of disease in captive animals. Here, we report a 16S rRNA sequencing-based bacterial profile during the progression of cardiovascular disease and drug treatment in a captive giant panda (Ailuropoda melanoleuca). We observed changes in the composition of bacteria associated with inflammation and regulating nutrient metabolism. Predicted metabolic functions also exhibited alterations. The remarkably reduced gut microbiome diversity, along with the imbalance in community interaction networks, indicated possible gut dysfunction. Our findings represent the first description of gut bacterial changes in a giant panda with cardiovascular disease. Maintaining symbiotic bacteria diversity is crucial for preventing health issues in captive animals and advancing wildlife conservation efforts.

Indexed as

Cardiovascular DiseasesGastrointestinal MicrobiomeUrsidaeAnimalsAnimals, ZooBacteriaMaleRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNAAiluropoda melanoleucacardiovascular diseasegiant pandagut microbiome

Identifiers

PMID42457551
PMCPMC13616597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.